SAN FRANCISCO, CA, Distributional, the modern enterprise platform for AI testing, announced today that it has raised $19 million in Series A funding. Read More
BOSTON, MA, FutureMoney, a digital platform designed to help families invest for their children, announced that it has successfully closed a $2.5M pre-seed funding round. Read More
SAN FRANCISCO, CA, Arda Therapeutics, a pioneer in targeted cell depletion therapies for chronic diseases, announced the successful completion of a $43 million Series A financing round. The round was led by existing investor Andreessen Horowitz. Read More
NEW YORK, NY, Wayvee Analytics, a customer satisfaction analytics innovator for brick-and-mortar retailers, emerged from stealth with $5 million in pre-seed funding led by Tetrad.vc. Read More
NEW YORK, NY, Prime Security emerged from stealth backed by $6 million in seed funding with an AI-powered solution that lets security teams build guardrails into the software design phase to detect, prioritize and mitigate security and compliance risks before development starts. Read More
SAN DIEGO, CA, Amprion, a global leader advancing diagnoses of neurodegenerative disorders, announced the successful initial $6 million close of a $15 million Series B financing, led by Formation Venture Engineering. Read More
LOS ANGELES, CA, MeWe, the pioneering privacy-first social media network, announced the opening of the $6 Million Series B round, led by McCourt Global. Read More
CHARLESTON, SC, Case Status, the leading AI-powered client engagement platform for law firms, announced the successful close of its Series B funding round securing $19.7 million. Read More
SAN FRANCISCO, CA, Vultron, an AI-powered proposal development solution for the public sector, announced that it has secured $4.85 million in seed funding. Read More
EVERETT, WA, Zap Energy has begun operations of Century, its new high-rep-rate, liquid-metal-cooled fusion test platform, and closed $130 Series D funding. Read More
MINNEAPOLIS, MN, ShiraTronics, a clinical-stage medical device company developing neurostimulation therapies for chronic migraine patients, today announced the closing of a $66 million Series B financing. Read More
